BIOCON LTD.
BSE: 532523
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 621.30+6.5% | 583.30+8.6% | 537.10-16.6% | 643.80+14.4% | 562.80+7.1% | 525.40 |
| Other Income | 74.80-44.1% | 133.80+118.3% | 61.30-2.2% | 62.70-2.3% | 64.20-12.7% | 73.50 |
| Total Income | 696.10-2.9% | 717.10+19.8% | 598.40-15.3% | 706.50+12.7% | 627.00+4.7% | 598.90 |
| EXPENSES | ||||||
| Expenditure | 584.30-7.5% | 631.40+4.2% | 606.00-9.8% | 671.50+6.5% | 630.60+9.1% | 578.00 |
| Tax | -8.10-154.7% | 14.80+2014.3% | 0.70-94.9% | 13.80-30.7% | 19.90+12.4% | 17.70 |
| PROFIT | ||||||
| PBT | -84.50-198.6% | 85.70+1227.6% | -7.60-121.7% | 35.00-94.2% | 603.90+2789.5% | 20.90 |
| Net Profit | -76.40-207.8% | 70.90+954.2% | -8.30-139.2% | 21.20-96.4% | 584.00+18150.0% | 3.20 |
| KEY METRICS | ||||||
| OPM % | -19.80%-28.87pp | 9.07%+5.23pp | 3.84%-5.79pp | 9.63%-68.66pp | 78.29%+105.47pp | -27.18% |
| NPM % | -10.98%-20.87pp | 9.89%+11.28pp | -1.39%-4.39pp | 3.00%-90.14pp | 93.14%+92.61pp | 0.53% |
| EPS | 0.57+3.6% | 0.55+685.7% | 0.07-61.1% | 0.18-96.3% | 4.88+16166.7% | 0.03 |
Corporate Events
Board MeetingBIOCON
202612Feb
Board Meeting
Intimation for the Board Meeting, approve and take on record…
BSE Filing ↗ Board MeetingBIOCON
20256Dec
Board Meeting
Intimation of Board Meeting Regulations, 2015, investment in…
BSE Filing ↗ Board MeetingBIOCON
202511Nov
Board Meeting
Consider and approve Intimation of the date of Board Meeting…
BSE Filing ↗ Board MeetingBIOCON
20258May
Board Meeting
Board Meeting Intimation, Consider and approve Board Meeting…
BSE Filing ↗ Board MeetingBIOCON
202430Oct
Board Meeting
Consider and approve Intimation for board meeting, approve a…
BSE Filing ↗ Board MeetingBIOCON
20248Aug
Board Meeting
approval of the un-audited financial, to consider and approv…
BSE Filing ↗ Board MeetingBIOCON
202416May
Board Meeting
Consider and approve Audited standalone and consolidated fin…
BSE Filing ↗ Board MeetingBIOCON
202310Nov
Board Meeting
Consider and approve un-audited standalone and consolidated …
BSE Filing ↗